Peptoid–Peptide Hybrids That Bind Syk SH2 Domains Involved in Signal Transduction

Peptoid–peptide hybrids are oligomeric peptidomimetics that contain one or more N‐substituted glycine residues. In these hybrids, the side chains of one or several amino acids are “shifted” from the α‐carbon atom to the amide nitrogen atom. A library of phosphorylated peptoid–peptide hybrids derived from the sequence pTyr‐Glu‐Thr‐Leu was synthesized and tested for binding to the tandem SH2 domain of the protein tyrosine kinase Syk. A considerable influence of the side chain position was observed. Compounds 19–21, 24, and 25 comprising a peptoid NpTyr and/or NGlu residue did not show any binding. Compounds 22, 23, and 26 containing an NhThr (hThr=homothreonine) and/or NLeu peptoid residue showed binding with IC50 values that were only five to eight times higher than that of the tetrapeptide lead compound 18. These data show that side chain shifting is possible with retention of binding capacity, but only at the two C‐terminal residues of the tetramer. This method of a peptoid scan using peptoid–peptide hybrids appears to be very useful to explore to what extent a peptide sequence can be transformed into a peptoid while retaining its affinity.

[1]  M. Fischer,et al.  Kinetic analysis of the mass transport limited interaction between the tyrosine kinase lck SH2 domain and a phosphorylated peptide studied by a new cuvette-based surface plasmon resonance instrument. , 2000, Analytical biochemistry.

[2]  J. D. Di Santo,et al.  Tyrosine kinase SYK: essential functions for immunoreceptor signalling. , 2000, Immunology today.

[3]  R. Panek,et al.  Progress in the development of inhibitors of SH2 domains. , 2000, Current pharmaceutical design.

[4]  E. De Clercq,et al.  A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry. , 2000, Molecular pharmacology.

[5]  J. Kinet,et al.  Signalling through the high-affinity IgE receptor FcεRI , 1999, Nature.

[6]  R S Bohacek,et al.  Discovery of potent and selective SH2 inhibitors of the tyrosine kinase ZAP-70. , 1999, Journal of medicinal chemistry.

[7]  W. Moos,et al.  Combinatorial discovery process yields antimicrobial peptoids. , 1999, Bioorganic & medicinal chemistry.

[8]  F. Tse,et al.  Absorption and disposition of a tripeptoid and a tetrapeptide in the rat , 1999, Biopharmaceutics & drug disposition.

[9]  C. Beglinger,et al.  A combinatorial peptoid library for the identification of novel MSH and GRP/bombesin receptor ligands. , 1999, Journal of receptor and signal transduction research.

[10]  F E Cohen,et al.  Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors. , 1998, Science.

[11]  A. Weiss,et al.  The Syk family of protein tyrosine kinases in T‐cell activation and development , 1998, Immunological reviews.

[12]  G Waksman,et al.  Structural basis for Syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide. , 1998, Journal of molecular biology.

[13]  R. Liskamp,et al.  Solid‐Phase Syntheses of Peptoids using Fmoc‐Protected N‐Substituted Glycines: The Synthesis of (Retro)Peptoids of Leu‐Enkephalin and Substance P , 1998 .

[14]  K A Dill,et al.  NMR determination of the major solution conformation of a peptoid pentamer with chiral side chains. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  L. Révész,et al.  Solid phase synthesis of a biased mini tetrapeptoid-library for the discovery of monodentate ITAM mimics as ZAP-70 inhibitors. , 1998, Bioorganic & medicinal chemistry letters.

[16]  T K Sawyer,et al.  Src homology‐2 domains: Structure, mechanisms, and drug discovery , 1998, Biopolymers.

[17]  L. Révész,et al.  Non-peptide itam mimics as ZAP-70 antagonists , 1997 .

[18]  J. Rivera,et al.  ER-27319, an acridone-related compound, inhibits release of antigen-induced allergic mediators from mast cells by selective inhibition of fcepsilon receptor I-mediated activation of Syk. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Wright,et al.  Convenient preparations of t-butyl esters and ethers from t-butanol , 1997 .

[20]  R. Liskamp,et al.  Comparing mass spectrometric characteristics of peptides and peptoids-2 , 1997 .

[21]  D. Spellmeyer,et al.  Pharmacologic characterization of CHIR 2279, an N-substituted glycine peptoid with high-affinity binding for alpha 1-adrenoceptors. , 1996, The Journal of pharmacology and experimental therapeutics.

[22]  H. Sakamoto,et al.  Conformational changes induced in the protein tyrosine kinase p72syk by tyrosine phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-based activation motif peptides , 1996, Molecular and cellular biology.

[23]  S. Rhee,et al.  Molecular Cloning, Splice Variants, Expression, and Purification of Phospholipase C-4 (*) , 1996, The Journal of Biological Chemistry.

[24]  R. Zuckermann,et al.  Synthesis of N-substituted glycine peptoid libraries. , 1996, Methods in enzymology.

[25]  C. D. de Koster,et al.  Comparing mass spectrometric characteristics of peptides and peptoids. , 1996, Rapid communications in mass spectrometry : RCM.

[26]  H. Kalbitzer,et al.  Chemical phosphorylation of the peptides GGXA (X = S, T, Y): an evaluation of different chemical approaches. , 2009, International journal of peptide and protein research.

[27]  M. Hatada,et al.  Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide. , 1995, Structure.

[28]  R. Liskamp,et al.  Synthesis in solution of peptoids using fmoc-protected n-substituted glycines , 1995 .

[29]  A. Andres,et al.  Molecular characterization of the murine syk protein tyrosine kinase cDNA, transcripts and protein. , 1995, Biochemical and biophysical research communications.

[30]  J. Brugge,et al.  Syk Is Activated by Phosphotyrosine-containing Peptides Representing the Tyrosine-based Activation Motifs of the High Affinity Receptor for IgE(*) , 1995, The Journal of Biological Chemistry.

[31]  S. Jakes,et al.  Determination of receptor-ligand kinetic and equilibrium binding constants using surface plasmon resonance: application to the lck SH2 domain and phosphotyrosyl peptides. , 1995, Journal of medicinal chemistry.

[32]  J M Thornton,et al.  LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.

[33]  J. Bolen,et al.  Interaction of p72syk with the gamma and beta subunits of the high-affinity receptor for immunoglobulin E, Fc epsilon RI , 1995, Molecular and cellular biology.

[34]  R. Zuckermann,et al.  Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers , 1994 .

[35]  D C Spellmeyer,et al.  Discovery of nanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N-(substituted)glycine peptoid library. , 1994, Journal of medicinal chemistry.

[36]  Horst Kessler,et al.  Peptoids—A New Approach to the Development of Pharmaceuticals , 1993 .

[37]  H. Kessler.  Peptoide – Schlüsselverbindungen für einen neuen Weg zur Entwicklung von pharmazeutischen Wirkstoffen , 1993 .

[38]  J. Kuriyan,et al.  Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: Crystal structures of the complexed and peptide-free forms , 1993, Cell.

[39]  S. Harrison,et al.  Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck , 1993, Nature.

[40]  Stephen B. H. Kent,et al.  Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis , 1992 .

[41]  L Wang,et al.  Peptoids: a modular approach to drug discovery. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Hutchcroft,et al.  Fc epsilon RI-mediated tyrosine phosphorylation and activation of the 72-kDa protein-tyrosine kinase, PTK72, in RBL-2H3 rat tumor mast cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Bolen,et al.  Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases , 1992, Nature.

[44]  J. Perich,et al.  Fmoc/solid-phase synthesis of Tyr(P)-containing peptides through t-butyl phosphate protection. , 2009, International journal of peptide and protein research.

[45]  T Pawson,et al.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.

[46]  K. Robbins,et al.  Tyrosine phosphorylation coupled to IgE receptor-mediated signal transduction and histamine release. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S. Daniels,et al.  A comparison of acid labile linkage agents for the synthesis of peptide C-terminal amides , 1989 .

[48]  A. Trzeciak,et al.  A Simple and Effective Chemical Phosphorylation Procedure for Biomolecules , 1987 .

[49]  H. Rink.  Solid-phase synthesis of protected peptide fragments using a trialkoxy-diphenyl-methylester resin. , 1987 .

[50]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[51]  E. V. Arx,et al.  Das 4,4′-tetramethyldiamino-diphenylmethan reagens (TDM) , 1976 .